- Motley Fool•13 hours ago
Which stock wins in a matchup between these big drugmakers?
- Motley Fool•23 hours ago
Short-sellers have pounced on Intercept's stock. But could their pessimism be short-sighted?
- Motley Fool•yesterday
Gilead Sciences' approach to curing illnesses has made this a terrible investment for investors over the last couple years -- but it could be the cure to rising healthcare costs.
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||69.87 x 100|
|Ask||70.25 x 300|
|Day's Range||69.71 - 70.79|
|52 Week Range||65.38 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||7.03|
|Dividend & Yield||2.08 (2.98%)|
|1y Target Est||N/A|